Cargando…

Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis

CONTEXT: Previous reports have shown an association between vasectomy and prostate cancer (PCa). However, there exist significant discrepancies between studies and systematic reviews due to a lack of strong causal association and residual confounding factors such as prostate-specific antigen (PSA) s...

Descripción completa

Detalles Bibliográficos
Autores principales: Baboudjian, Michael, Rajwa, Pawel, Barret, Eric, Beauval, Jean-Baptiste, Brureau, Laurent, Créhange, Gilles, Dariane, Charles, Fiard, Gaëlle, Fromont, Gaëlle, Gauthé, Mathieu, Mathieu, Romain, Renard-Penna, Raphaële, Roubaud, Guilhem, Ruffion, Alain, Sargos, Paul, Rouprêt, Morgan, Ploussard, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130083/
https://www.ncbi.nlm.nih.gov/pubmed/35633829
http://dx.doi.org/10.1016/j.euros.2022.04.012
_version_ 1784712910622162944
author Baboudjian, Michael
Rajwa, Pawel
Barret, Eric
Beauval, Jean-Baptiste
Brureau, Laurent
Créhange, Gilles
Dariane, Charles
Fiard, Gaëlle
Fromont, Gaëlle
Gauthé, Mathieu
Mathieu, Romain
Renard-Penna, Raphaële
Roubaud, Guilhem
Ruffion, Alain
Sargos, Paul
Rouprêt, Morgan
Ploussard, Guillaume
author_facet Baboudjian, Michael
Rajwa, Pawel
Barret, Eric
Beauval, Jean-Baptiste
Brureau, Laurent
Créhange, Gilles
Dariane, Charles
Fiard, Gaëlle
Fromont, Gaëlle
Gauthé, Mathieu
Mathieu, Romain
Renard-Penna, Raphaële
Roubaud, Guilhem
Ruffion, Alain
Sargos, Paul
Rouprêt, Morgan
Ploussard, Guillaume
author_sort Baboudjian, Michael
collection PubMed
description CONTEXT: Previous reports have shown an association between vasectomy and prostate cancer (PCa). However, there exist significant discrepancies between studies and systematic reviews due to a lack of strong causal association and residual confounding factors such as prostate-specific antigen (PSA) screening. OBJECTIVE: To assess the association between vasectomy and PCa, in both unadjusted and PSA screen-adjusted studies. EVIDENCE ACQUISITION: We performed a systematic review according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses. The PubMed, Scopus, and Web of Science databases were searched in January 2022 for studies that analyzed the association between vasectomy and PCa. EVIDENCE SYNTHESIS: A total of 37 studies including 16 931 805 patients met our inclusion criteria. A pooled analysis from all studies showed a significant association between vasectomy and any-grade PCa (odds ratio [OR] 1.23; 95% confidence interval [CI], 1.10–1.37; p < 0.001; I(2) = 96%), localized PCa (OR 1.08; 95% CI, 1.06–1.11; p < 0.00001; I(2) = 31%), or advanced PCa (OR 1.07; 95% CI, 1.02–1.13; p = 0.006; I(2) = 0%). The association with PCa remained significant when the analyses were restricted to studies with a low risk of bias (OR 1.06; 95% CI, 1.02–1.10; p = 0.02; I(2) = 48%) or cohort studies (OR 1.09; 95% CI, 1.04–1.13; p < 0.0001; I(2) = 64%). Among studies adjusted for PSA screening, the association with localized PCa (OR 1.06; 95% CI, 1.03–1.09; p < 0.001; I(2) = 0%) remained significant. Conversely, vasectomy was no longer associated with localized high-grade (p = 0.19), advanced (p = 0.22), and lethal (p = 0.42) PCa. CONCLUSIONS: Our meta-analysis found an association between vasectomy and any, mainly localized, PCa. However, the effect estimates of the association were increasingly close to null when examining studies of robust design and high quality. On exploratory analyses including studies, which adjusted for PSA screening, the association for aggressive and/or advanced PCa diminished. PATIENT SUMMARY: In this study, we found an association between vasectomy and the risk of developing localized prostate cancer without being able to determine whether the procedure leads to a higher prostate cancer incidence.
format Online
Article
Text
id pubmed-9130083
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91300832022-05-26 Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis Baboudjian, Michael Rajwa, Pawel Barret, Eric Beauval, Jean-Baptiste Brureau, Laurent Créhange, Gilles Dariane, Charles Fiard, Gaëlle Fromont, Gaëlle Gauthé, Mathieu Mathieu, Romain Renard-Penna, Raphaële Roubaud, Guilhem Ruffion, Alain Sargos, Paul Rouprêt, Morgan Ploussard, Guillaume Eur Urol Open Sci Review – Prostate Cancer CONTEXT: Previous reports have shown an association between vasectomy and prostate cancer (PCa). However, there exist significant discrepancies between studies and systematic reviews due to a lack of strong causal association and residual confounding factors such as prostate-specific antigen (PSA) screening. OBJECTIVE: To assess the association between vasectomy and PCa, in both unadjusted and PSA screen-adjusted studies. EVIDENCE ACQUISITION: We performed a systematic review according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses. The PubMed, Scopus, and Web of Science databases were searched in January 2022 for studies that analyzed the association between vasectomy and PCa. EVIDENCE SYNTHESIS: A total of 37 studies including 16 931 805 patients met our inclusion criteria. A pooled analysis from all studies showed a significant association between vasectomy and any-grade PCa (odds ratio [OR] 1.23; 95% confidence interval [CI], 1.10–1.37; p < 0.001; I(2) = 96%), localized PCa (OR 1.08; 95% CI, 1.06–1.11; p < 0.00001; I(2) = 31%), or advanced PCa (OR 1.07; 95% CI, 1.02–1.13; p = 0.006; I(2) = 0%). The association with PCa remained significant when the analyses were restricted to studies with a low risk of bias (OR 1.06; 95% CI, 1.02–1.10; p = 0.02; I(2) = 48%) or cohort studies (OR 1.09; 95% CI, 1.04–1.13; p < 0.0001; I(2) = 64%). Among studies adjusted for PSA screening, the association with localized PCa (OR 1.06; 95% CI, 1.03–1.09; p < 0.001; I(2) = 0%) remained significant. Conversely, vasectomy was no longer associated with localized high-grade (p = 0.19), advanced (p = 0.22), and lethal (p = 0.42) PCa. CONCLUSIONS: Our meta-analysis found an association between vasectomy and any, mainly localized, PCa. However, the effect estimates of the association were increasingly close to null when examining studies of robust design and high quality. On exploratory analyses including studies, which adjusted for PSA screening, the association for aggressive and/or advanced PCa diminished. PATIENT SUMMARY: In this study, we found an association between vasectomy and the risk of developing localized prostate cancer without being able to determine whether the procedure leads to a higher prostate cancer incidence. Elsevier 2022-05-19 /pmc/articles/PMC9130083/ /pubmed/35633829 http://dx.doi.org/10.1016/j.euros.2022.04.012 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review – Prostate Cancer
Baboudjian, Michael
Rajwa, Pawel
Barret, Eric
Beauval, Jean-Baptiste
Brureau, Laurent
Créhange, Gilles
Dariane, Charles
Fiard, Gaëlle
Fromont, Gaëlle
Gauthé, Mathieu
Mathieu, Romain
Renard-Penna, Raphaële
Roubaud, Guilhem
Ruffion, Alain
Sargos, Paul
Rouprêt, Morgan
Ploussard, Guillaume
Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis
title Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis
title_full Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis
title_fullStr Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis
title_full_unstemmed Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis
title_short Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis
title_sort vasectomy and risk of prostate cancer: a systematic review and meta-analysis
topic Review – Prostate Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130083/
https://www.ncbi.nlm.nih.gov/pubmed/35633829
http://dx.doi.org/10.1016/j.euros.2022.04.012
work_keys_str_mv AT baboudjianmichael vasectomyandriskofprostatecancerasystematicreviewandmetaanalysis
AT rajwapawel vasectomyandriskofprostatecancerasystematicreviewandmetaanalysis
AT barreteric vasectomyandriskofprostatecancerasystematicreviewandmetaanalysis
AT beauvaljeanbaptiste vasectomyandriskofprostatecancerasystematicreviewandmetaanalysis
AT brureaulaurent vasectomyandriskofprostatecancerasystematicreviewandmetaanalysis
AT crehangegilles vasectomyandriskofprostatecancerasystematicreviewandmetaanalysis
AT darianecharles vasectomyandriskofprostatecancerasystematicreviewandmetaanalysis
AT fiardgaelle vasectomyandriskofprostatecancerasystematicreviewandmetaanalysis
AT fromontgaelle vasectomyandriskofprostatecancerasystematicreviewandmetaanalysis
AT gauthemathieu vasectomyandriskofprostatecancerasystematicreviewandmetaanalysis
AT mathieuromain vasectomyandriskofprostatecancerasystematicreviewandmetaanalysis
AT renardpennaraphaele vasectomyandriskofprostatecancerasystematicreviewandmetaanalysis
AT roubaudguilhem vasectomyandriskofprostatecancerasystematicreviewandmetaanalysis
AT ruffionalain vasectomyandriskofprostatecancerasystematicreviewandmetaanalysis
AT sargospaul vasectomyandriskofprostatecancerasystematicreviewandmetaanalysis
AT roupretmorgan vasectomyandriskofprostatecancerasystematicreviewandmetaanalysis
AT ploussardguillaume vasectomyandriskofprostatecancerasystematicreviewandmetaanalysis
AT vasectomyandriskofprostatecancerasystematicreviewandmetaanalysis